Published: October 25, 2025
3
2
7

Immune related adverse events- an overview of the problem! πŸ”Ή>90% experience irAEs. Most common is rashπŸ₯΅ and least is myocarditis ❀️‍πŸ”₯ #ACR2025 #rheumatology

Image in tweet by Pankti Mehta

Most irAEs occur in the first 6 months! Hepatitis & hypophysitis can occur later

Image in tweet by Pankti Mehta

Why do irAEs happen?

Image in tweet by Pankti Mehta

How do we mitigate irAEs? ? Early detection: we don't have biomarkers!πŸ˜‘ βš–οΈ Stopping ICI or broad immunosuppression that can potentially affect anti-tumour immune response #ACR2025

An overview of the approach to define biomarkers for the most severe irAE ---> myocarditis ❀️‍πŸ”₯ What's in the? 🩸 What's in the tissue? πŸ«€ What correlates with severity? πŸ“ˆ What is the target antigen? 🎯 #ACR2025

Image in tweet by Pankti Mehta

@PanktiMehta24 Nice COI πŸ˜‚ CART collaboration trial/paper when

Beyond CAR-T @MaxKonigMD We heard about the cons of CAR-T therapy, what is the potential solution? BiTEs? #ACR25 #rheumatology

Image in tweet by Pankti Mehta

Share this thread

Read on Twitter

View original thread

Navigate thread

1/7